Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
Clinical trial NCT03175367 · COMPLETED
Trial details
- NCT number
- NCT03175367
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-10
- Primary completion
- 2020-05-22
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.